THORACIC NEOPLASMS
Clinical trials for THORACIC NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new THORACIC NEOPLASMS trials appear
Sign up with your email to follow new studies for THORACIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lung cancer patients: maintenance drug aims to keep disease at bay
Disease control Recruiting nowThis study tests a drug called tarlatamab as a maintenance treatment for people with limited-stage small cell lung cancer who cannot receive standard combined chemotherapy and radiation. After completing chemotherapy with or without radiation, participants who have not gotten wor…
Matched conditions: THORACIC NEOPLASMS
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a simple diet cut hospital stays after lung surgery by 30%?
Disease control Recruiting nowThis study tests whether a medium-chain triglyceride (MCT) diet, given after lung resection surgery, can help people leave the hospital sooner. The diet bypasses the lymphatic system, potentially reducing fluid buildup and complications. Researchers will compare hospital stay len…
Matched conditions: THORACIC NEOPLASMS
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New drug aims to shield cancer patients from chemo side effect
Disease control Recruiting nowThis study tests whether a drug called mecapegfilgrastim can safely prevent moderate-to-severe myelosuppression (low blood cell counts) caused by chemotherapy and radiation for lung or esophageal cancer. About 30 adults aged 18-75 will receive the drug alongside their standard ca…
Matched conditions: THORACIC NEOPLASMS
Phase: PHASE2 • Sponsor: Affiliated Hospital of Nantong University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Hope for aggressive lung cancer: targeted drug trial opens
Disease control Recruiting nowThis study tests a drug called teniposide in people with a fast-growing type of lung cancer (extensive-stage small cell lung cancer) that has a specific gene change (c-Myc-driven). The cancer must have gotten worse after standard treatments. The goal is to see if teniposide can s…
Matched conditions: THORACIC NEOPLASMS
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Blood test may personalize lung cancer therapy
Disease control Recruiting nowThis study tests whether a simple blood test (ctDNA) can help doctors decide if adding chemotherapy to the immunotherapy drug cemiplimab works better for advanced lung cancer. About 63 people with stage IV or stage IIIB/C non-small cell lung cancer that hasn't been treated before…
Matched conditions: THORACIC NEOPLASMS
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New combo tackles back pain from spine tumors
Symptom relief Recruiting nowThis study tests whether combining three treatments—kyphoplasty (spine stabilization), radiofrequency ablation (heat to destroy tumor tissue), and standard radiation—can better reduce pain from spine tumors. About 70 adults with cancer that has spread to the middle or lower back …
Matched conditions: THORACIC NEOPLASMS
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Could a simple injection cut opioid use after lung surgery?
Symptom relief Recruiting nowThis study tests whether injecting a numbing medicine (bupivacaine) near the spine can reduce pain and the need for opioid painkillers after lung surgery. Researchers will track pain scores and medication use in 70 adults undergoing lung tumor removal. The goal is to find a safer…
Matched conditions: THORACIC NEOPLASMS
Phase: PHASE4 • Sponsor: George Washington University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
7,000 patients join tissue bank to unlock secrets of lung disease
Knowledge-focused Recruiting nowThis study is building a large collection of blood, tissue, and fluid samples from 7,000 people with lung cancer, other chest diseases, or lung transplants. The goal is to help researchers learn more about what causes these diseases, how to find them early, and how to treat them …
Matched conditions: THORACIC NEOPLASMS
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC